
Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

